Latest Valuation News

Hotel Property Investments (HPI) reported a robust half-year profit of A$16.7 million, driven by rising rental income and property valuations, while managing significant takeover defence costs amid Charter Hall Retail REIT and Hostplus bids.

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

Polymetals Resources Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could reshape investor expectations.

JPMorgan Asset Management has announced the final cash distributions for February 2025 across several of its active ETFs, providing investors with key dates and reinvestment options.

Citigroup Global Markets Australia has announced an unfranked dividend of AUD 0.204 for its AMC CitiFirst Instalment MINIs, with key dates set for late February and mid-March 2025.

Garda Property Group has reaffirmed its FY25 income return at 7.2 cents per security and upgraded its distribution payout ratio to 95% of FFO. The group plans to sell its North Lakes industrial site for $114 million and is marketing its Cairns Corporate Tower, aiming to reduce gearing and reposition as a focused industrial REIT.

Blackstone Minerals Limited has had its trading suspension lifted following a key announcement about a proposed merger, signaling renewed market interest.

Infini Resources has successfully raised AUD$3.4 million through a flow-through share placement at a significant premium, positioning the company to aggressively advance exploration at its Portland Creek Uranium Project in Newfoundland.

Magellan Financial Group reported a stable funds under management (FUM) figure of A$39.1 billion for January 2025, with flat flows across both retail and institutional segments.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

QMines Limited has reported outstanding near-surface copper intersections at its Develin Creek project, confirming the continuity of high-grade mineralisation at the Scorpion deposit and setting the stage for imminent resource upgrades and further drilling.

Barton Gold has completed a 2,230m follow-up drilling campaign at its Tolmer prospect, revealing impressive high-grade gold and silver assays that could reshape the project’s potential.